B

BridgeBio

Develops therapies for genetic diseases

Senior Director - Market Access, International

Biology & BiotechConfirmed live in the last 24 hours
Full-timeZug, SwitzerlandNo salary listed

About the Job

Requirements

  • Extensive experience leading health technology assessment submissions and pricing negotiations across multiple international markets, ideally including Europe and other global regions, particularly in rare diseases and orphan conditions.
  • Strong knowledge of international healthcare systems, pricing and reimbursement frameworks, and regulatory environments.
  • Experience generating and leveraging data for health technology assessment submissions and pricing negotiations, with a strong external network of agencies and stakeholders.
  • Ability to present at senior levels and engage with external thought leaders globally.
  • Proven experience managing complex, cross-functional and multicultural teams, including external partners.
  • Knowledge of product commercialization processes and a hands-on, solution-oriented mindset for building scalable processes and documentation.

Responsibilities

  • Represent the payer perspective within cross-functional, cross-regional commercialization teams to optimize pricing and market access of the asset.
  • Collaborate with health economics and outcomes research (HEOR), cluster leadership teams, Marketing, and Clinical Development counterparts to optimize value and access for the asset.
  • Lead early payer engagement with key health technology assessment (HTA) and payer bodies, including NICE in the UK and G-BA in Germany, to inform evidence-generation strategy, value proposition, and reimbursement dossier development.
  • Interact with internal and external experts in pricing, health economics, patient advocacy, health technology assessment authorities, government policy makers, and payers to execute pricing and reimbursement objectives.
  • Provide hands-on support and train local access teams on negotiation strategy, and ensure HTA and reimbursement submissions align with Global and International strategy.
  • Shape the value narrative and lead pricing and reimbursement strategies and execution across multiple international markets, including oversight of related dossiers, negotiations, and cost-coverage approaches.
  • Contribute to global decision-making as a core member of the International Market Access team and ensure alignment across regions while representing diverse market perspectives.

Desired Qualifications

  • Experience in rare diseases and orphan conditions is particularly desirable.

About the Company

BridgeBio

Develops therapies for genetic diseases

BridgeBio Pharma develops medicines for genetic diseases using a decentralized subsidiary model, where each subsidiary focuses on a specific disease while sharing central resources. It advances multiple drug programs at once by leveraging genome sequencing, molecular biology, and patient data to translate research into therapies that target underlying genetic causes. The company differentiates itself through its independent subsidiary structure with centralized support, combined with data-driven decision making and a culture of transparent, evidence-based testing. Its goal is to bring effective, disease-modifying therapies to patients faster by advancing a diverse pipeline from discovery to commercialization through partnerships and eventual approval.

Company size
1,001-5,000
Company stage
IPO
Headquarters
Palo Alto, CA
Founded
2014

Recently Posted Jobs

Explore more opportunities at BridgeBio

See more jobs